Get the Stockscreener App
1.59
1.27%
0.02
After Hours:
1.53
-0.06
-3.77%
Biorestorative Therapies Inc stock is traded at $1.59, with a volume of 4.99M.
It is up +1.27% in the last 24 hours and up +11.19% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.57
Open:
$1.6
24h Volume:
4.99M
Relative Volume:
34.47
Market Cap:
$12.69M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-1.1691
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
-1.85%
1M Performance:
+11.19%
6M Performance:
-7.02%
1Y Performance:
-1.85%
1-Day Range:
$1.45
$1.69
1-Week Range:
$1.45
$1.69
52-Week Range:
$1.19
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.59 | 12.53M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.17 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.58 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.31 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.83 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.02 | 33.75B | 398.11M | -1.03B | -868.57M | -5.7032 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
BioRestorative Therapies’ Promising Study on BRTX-100 for Lumbar Disc Disease - TipRanks
Is BioRestorative Therapies Inc. (9OF) stock a defensive play amid uncertaintyJuly 2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Why BioRestorative Therapies Inc. (9OF) stock stays on buy listsEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Biorestorative awarded notice of allowance for Japanese patent - MarketScreener
BioRestorative Therapies Says Granted Japanese Patent Allowance for Stem Cell Technology; Shares Up Pre-Bell - MarketScreener
BioRestorative Therapies, Inc. Receives Notice of Allowance for Japanese PatentExpands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar Glp-1 Drug Market - MarketScreener
BioRestorative Therapies Achieves Major Patent Milestone for ThermoStem® Platform in Japan - Quiver Quantitative
BioRestorative Awarded Notice of Allowance for Japanese PatentExpands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - The Manila Times
Using R and stats models for BioRestorative Therapies Inc. forecastingWeekly Trade Review & Entry Point Confirmation Signals - newser.com
BioRestorative (NASDAQ:BRTX) secures Japanese patent allowance for ThermoStem platform - Stock Titan
Published on: 2025-10-27 05:45:55 - newser.com
Will BioRestorative Therapies Inc. stock return to pre crisis levelsEarnings Recap Summary & Community Supported Trade Ideas - newser.com
BioRestorative Therapies Inc. stock chart pattern explainedMarket Risk Summary & Daily Profit Focused Screening - newser.com
Price momentum metrics for BioRestorative Therapies Inc. explained2025 Investor Takeaways & Risk Managed Trade Strategies - newser.com
Real time pattern detection on BioRestorative Therapies Inc. stockQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Identifying reversal signals in BioRestorative Therapies Inc.2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Why BioRestorative Therapies Inc. stock is recommended by analysts2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
Will earnings trigger a reversal in BioRestorative Therapies Inc.Quarterly Market Review & Weekly Top Gainers Trade List - newser.com
Published on: 2025-10-27 00:44:32 - newser.com
How currency fluctuations impact BioRestorative Therapies Inc. stockMarket Trend Report & Free Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-10-26 23:47:15 - newser.com
Chart based analysis of BioRestorative Therapies Inc. trendsPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
How to interpret RSI for BioRestorative Therapies Inc. stockJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Published on: 2025-10-26 18:59:00 - newser.com
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
2.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):